 |
MorphoSys AG
MOR
|
1.75 |
- |
2.43 % |
$ 254 M |
Germany |
 |
Ultragenyx Pharmaceutical
RARE
|
2.99 |
$ 19.23 |
-3.85 % |
$ 1.9 B |
USA |
 |
RedHill Biopharma Ltd.
RDHL
|
14 |
$ 0.8 |
0.89 % |
$ 428 M |
Israel |
 |
Dr. Reddy's Laboratories Limited
RDY
|
0.0568 |
$ 13.56 |
-1.56 % |
$ 2.25 B |
India |
 |
Regeneron Pharmaceuticals
REGN
|
5.67 |
$ 742.02 |
-1.94 % |
$ 77.6 B |
USA |
 |
Aeterna Zentaris
AEZS
|
7.87 |
- |
5.93 % |
$ 314 M |
Canada |
 |
AgeX Therapeutics
AGE
|
0.099 |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
Aeglea BioTherapeutics
AGLE
|
489 |
- |
- |
$ 1.01 B |
USA |
 |
AIkido Pharma
AIKI
|
1.08 |
- |
1.93 % |
$ 17.4 M |
USA |
 |
I-Mab
IMAB
|
94.1 |
- |
- |
$ 866 M |
China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 |
- |
- |
$ 40.3 B |
USA |
 |
Genfit SA
GNFT
|
1.96 K |
- |
2.54 % |
$ 160 B |
France |
 |
Albireo Pharma
ALBO
|
13.3 |
- |
-0.23 % |
$ 916 M |
USA |
 |
REGENXBIO
RGNX
|
2.6 |
$ 7.88 |
-4.6 % |
$ 406 M |
USA |
 |
Aptinyx
APTX
|
204 |
- |
-39.0 % |
$ 4.57 M |
USA |
 |
Midatech Pharma plc
MTP
|
137 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
Arena Pharmaceuticals
ARNA
|
105 K |
- |
-6.81 % |
$ 3.04 B |
USA |
 |
Rigel Pharmaceuticals
RIGL
|
2.03 |
$ 26.2 |
-0.64 % |
$ 471 M |
USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
65.5 |
- |
- |
$ 26.5 M |
USA |
 |
Ayala Pharmaceuticals
AYLA
|
11.2 |
- |
- |
$ 7.46 M |
Israel |
 |
Avidity Biosciences
RNA
|
535 |
$ 13.09 |
-0.08 % |
$ 1.8 B |
USA |
 |
Acorda Therapeutics
ACOR
|
0.142 |
- |
-24.86 % |
$ 820 K |
USA |
 |
bluebird bio
BLUE
|
2.27 |
- |
- |
$ 546 M |
USA |
 |
Acasti Pharma
ACST
|
0.203 |
- |
4.01 % |
$ 150 M |
Canada |
 |
Институт стволовых клеток человека
ISKJ
|
2.61 |
- |
- |
- |
Russia |
 |
Avid Bioservices
CDMO
|
3.03 |
- |
- |
$ 789 M |
USA |
 |
Adverum Biotechnologies
ADVM
|
76.4 |
- |
- |
$ 86.2 M |
USA |
 |
Acer Therapeutics
ACER
|
25.8 |
- |
2.71 % |
$ 14 M |
USA |
 |
Advaxis
ADXS
|
144 |
- |
-9.65 % |
$ 45.9 M |
USA |
 |
Rhythm Pharmaceuticals
RYTM
|
33.4 |
$ 78.52 |
-4.13 % |
$ 5.1 B |
USA |
 |
Adaptive Biotechnologies Corporation
ADPT
|
8.96 |
$ 12.57 |
-9.96 % |
$ 1.91 B |
USA |
 |
BeiGene, Ltd.
BGNE
|
66.4 |
- |
0.49 % |
$ 251 B |
Cayman-islands |
 |
SIGA Technologies
SIGA
|
4.27 |
$ 5.35 |
7.76 % |
$ 383 M |
USA |
 |
Alnylam Pharmaceuticals
ALNY
|
11 |
$ 321.71 |
-1.96 % |
$ 42.1 B |
USA |
 |
BioDelivery Sciences International
BDSI
|
1.85 |
- |
-4.8 % |
$ 255 M |
USA |
 |
Cara Therapeutics
CARA
|
2.58 |
- |
-3.03 % |
$ 260 M |
USA |
 |
ChemoCentryx
CCXI
|
0.0564 |
- |
- |
$ 3.74 B |
USA |
 |
Silence Therapeutics plc
SLN
|
119 |
$ 4.8 |
-9.6 % |
$ 622 M |
Britain |